No specific risk factors for clots with AstraZeneca Covid-19 jab


SINGAPORE (Bloomberg/Reuters/AFP): The AstraZeneca Covid-19 vaccine came under the spotlight following reports of rare blood clots, some of them fatal, among some adult vaccine recipients.

Concerns about the vaccine centred on an unusual type of blood clot in the brain called cerebral venous sinus thrombosis (CVST). There were also some cases of clots in the abdomen and in the arteries, which occurred together with low levels of blood platelets.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Aseanplus News

Asean news headlines as at 9pm on Thursday (April 18)
China's Wang Yi meets Indonesia's Jokowi, president-elect Prabowo
Philippines, N. Zealand eye forces deal, share concern over South China Sea
‘Charismatic, loving, a true friend’: Ex-colleagues remember S’porean woman killed in Spain
Barber shop at Brunei stadium gives youth founder an edge
Govt, private sectors extend support for school meals programme
Jokowi seeks ex-British PM Tony Blair's help to speed up Indonesia's digitalisation
Cadmium poisoning identified in 17 residents near Samut Sakhon factory
Siti Nurhaliza clarifies on her 'angry' facial expression at recent concert
Global suppliers join Beautycare Expo 2024 in Hanoi

Others Also Read